Bisphosphonates: Mechanism of Action and Role in Clinical Practice

This publication has 140 references indexed in Scilit:

• Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study
  BMJ, 2008
• Vitamin D Deficiency
  New England Journal of Medicine, 2007
• Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer
  Journal of Clinical Oncology, 2007
• Suppressed Bone Turnover during Alendronate Therapy for High-Turnover Osteoporosis
  New England Journal of Medicine, 2006
• Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
  New England Journal of Medicine, 2006
• The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs
  Proceedings of the National Academy of Sciences, 2006
• Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease
  New England Journal of Medicine, 2005
• Pharmacokinetics/Pharmacodynamics of Bisphosphonates
  Clinical Pharmacokinetics, 2005
• Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
  Journal of Bone and Mineral Research, 2004
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002